Bioseeker, Dec 2011
"AnalyticalTool - Apoptosis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer
Bioseeker, Dec 2011, Pages: 3579
on the following publication:
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises
Bioseeker, Dec 2011, Pages: 3670
on the following publication:
A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up
Bioseeker, Dec 2011, Pages: 3846
is based on the following publication:
Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined
Bioseeker, Dec 2011, Pages: 3477
on the following publication:
A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up
Bioseeker, Dec 2011, Pages: 3300
Support Tool for Optimizing the Melanoma Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up to date development strategies
Bioseeker, Dec 2011, Pages: 3361
:
A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up to date
Bioseeker, Dec 2011, Pages: 3182
are commercialized. Key Topics Covered:
Part I: Apoptosis
5.1 The Scope of this Report 33
6 Consider the Therapeutic Target Among Apoptotic Drugs in Oncology for the Highest Therapeutic Outcome and Return
Bioseeker, Jan 2012, Pages: 4377
:
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up to date
Bioseeker, Jan 2012, Pages: 4468
This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts
Bioseeker, Jan 2012, Pages: 4644
: A Decision Support Tool for Optimizing the Pipeline from Research To Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up to date development strategies for 234 drugs
Bioseeker, Jan 2012, Pages: 4275
This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts
Bioseeker, Jan 2012, Pages: 4098
: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up to date development strategies for 234 drugs in oncology within the portfolio
Bioseeker, Jan 2012, Pages: 4159
Cancer Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up to date development strategies for 234 drugs in oncology within
Bioseeker, Jan 2012, Pages: 3980
are commercialized. Key Topics Covered:
Part I: Apoptosis
5.1 The Scope of this Report 33
6 Consider the Therapeutic Target Among Apoptotic Drugs in Oncology for the Highest Therapeutic Outcome and Return
Bioseeker, Dec 2011, Pages: 4617
on the following publication:
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises
Bioseeker, Dec 2011, Pages: 4708
on the following publication:
A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up
Bioseeker, Dec 2011, Pages: 4884
is based on the following publication:
Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined
Bioseeker, Dec 2011, Pages: 4515
on the following publication:
A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up
Bioseeker, Dec 2011, Pages: 4338
Support Tool for Optimizing the Melanoma Pipeline: From Research and Development to Market
Part II: Apoptosis
The apoptotic cancer drug report part comprises defined and up to date development strategies